Dexamethasone, an inhibitor of the expression of the inducible nitric oxide synthase, does not modify hyperdynamic state in cirrhotic rats;La dexametasona, un inhibidor de la expresion de la oxido nitrico sintasa inducible, no modifica el estado hiperdinamico en ratas cirroticas

Medicina

Volumn 60, Issue 4, 2000, Pages 477-481

  Albornoz, L ^a   Bandi, J C ^a   De las Heras, M ^a   Mastai, R ^a  

^a HOSPITAL ALEMÁN   (Argentina)

Author keywords

Cirrhosis; Dexamethasone; Nitric oxide; Portal hypertension; Systemic and splanchnic hemodynamics

Indexed keywords

DEXAMETHASONE; ENDOTOXIN; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ENZYME ACTIVITY; ENZYME SYNTHESIS; HEART OUTPUT; LIVER CIRRHOSIS; MALE; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN BLOOD FLOW; RAT; VASCULAR RESISTANCE;

ANIMALS; BLOOD PRESSURE; BODY WEIGHT; DEXAMETHASONE; ENDOTOXINS; ENZYME INHIBITORS; GLUCOCORTICOIDS; HEMODYNAMIC PROCESSES; LIVER CIRRHOSIS; MALE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PORTAL PRESSURE; RATS; RATS, WISTAR; SPLANCHNIC CIRCULATION; SPLEEN;

EID: 0033859499     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. The L-arginine-nitric oxide pathway
2. Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension
3. The role of nitric oxide in the vascular hyporesponsiveness to methoxamine in portal hypertensive rats
4. Papel del oxido nitrico en las alteraciones de la hemodinamica sistemica y esplacnica en un modelo experimental de hipertension portal
5. Modulation of the hyperdinamic circulation of cirrhotic rats by nitric oxide inhibition
6. Hemodynamic characterization of chronic bile-duct ligated rats: Effects of pentobarbital sodium
7. Antiinflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthase in the lung, liver and aorta of the rat
8. Differential induction of brain, lung and liver nitric oxide synthase by endotoxin in the rat
9. Forward and backward flow mechanisms of portal hypertension: Relative contributions in the rat model of portal vein stenosis
10. Role of glucagon in splanchnic hyperemia of chronic portal hypertension
11. Blood flow measurements by the reference sample method with microsphere injection into the aorta: An accurate and easy approach
12. Detection of endotoxin in human blood and demonstration of an inhibitor
13. Nitric oxide synthase isozymes. Characterization, purification, molecular cloning and functions
14. N-nitro-L-arginine: A potent inhibitor of EDRF formation
15. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo
16. Nitric oxide mediates hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats
17. Hyperdynamic circulation in cirrhosis: A role for nitric oxide?
18. Chronic low dose infusion of dexamethasone in rats: Effects on blood pressure, body weight and plasma atrial natriuretic peptide
19. Role of antiglucorticoid RU486 on dexamethasone induce hypertension in rats
20. Dexamethasone hypertension in rats: Role of prostaglandins and pressor sensitivity to norepinephrine hypertension
21. Blockade of glucorticoid receptor binding and inhibition of dexamethasone-induced muscle atrophy in the rat by Ru 38486, a potent glucocorticoid antagonist
22. Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hyperensive rats
23. Enhanced nitric oxide synthase activity in portal hypertensive rabbits
24. Induction of nitric oxide synthase II does not account for excess vascular nitric oxide production in experimental cirrhosis
25. Nitric oxide and portal hypertension